Only physicians have the right to access trial data.

The trial results will be published in high-impact journals.

Participants are compensated financially regardless of study outcomes.

Participants are aware of potential risks and voluntarily agree to participate.

A preliminary analysis conducted before a trial starts.

The statistical software used for data analysis.

The main outcome used to assess the effectiveness of an intervention.

The number of participants enrolled in a study.

A secondary measure that supports the main research findings.

To eliminate the need for placebo groups.

To increase the number of participants in the trial.

To reduce study duration.

To balance participant characteristics across treatment groups.

To allow researchers to control the final results.

To adjust the research question to align with current trends.

To ensure the study follows ethical guidelines and protects participants.

To approve the study without modifications.

To evaluate whether the research will be financially profitable.

To determine the expected impact factor of the final publication.

They minimize bias by randomly assigning participants to groups.

They do not require ethical approval before starting.

They eliminate all sources of bias in research.

They use pre-existing data to analyze outcomes.

They require fewer participants than observational studies.

To determine the long-term effects and adverse reactions.

To evaluate whether the drug is more effective than current treatments.

To assess the safety and appropriate dosage of the medication in healthy volunteers.

To determine the cost-effectiveness of the new drug.

To compare the drug with alternative therapies in a large population.

To legally bind the participant to complete the study.

To ensure the participant fully understands the study before enrolling.

To provide a summary of study outcomes before data collection.

To collect financial information from participants.

To confirm that participants will not withdraw from the study.

To determine the statistical significance of the treatment.

To establish the cost-effectiveness of the drug.

To monitor side effects without measuring effectiveness.

To observe long-term trends without intervention.

To compare the safety and efficacy of the medication.

Once the patient receives a referral from another doctor.

After reviewing the patient’s medical history and confirming eligibility.

When the patient verbally agrees to participate.

After the patient reads, discusses, and signs two copies of the informed consent form.

After the research team completes data collection from previous studies.

To provide financial details of the research budget.

To summarize previous studies on osteoarthritis treatments.

To collect participant feedback before the trial begins.

To list the names of all researchers involved in the study.

To outline the study’s objectives, methodology, and procedures.